Balance Sheet NuGen Medical Devices Inc.

Stocks

NGMD

CA67054F1009

Medical Equipment, Supplies & Distribution

Delayed Toronto S.E. Other stock markets 01:19:08 2026-06-15 pm EDT			5-day change	1st Jan Change
0.0200 ^CAD	0.00%		0.00%	-33.33%

Jun. 01	NuGen Medical Devices Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Apr. 29	NuGen Medical Devices Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

9f786c4c740d7df516303d6357aa.W4zAAP-YhKOmPlIRirUgExFbgvDOvOGhZsIf18V-Vvo.Arr4b6rhyObHCxRVxudXZ30Z6Yn_5KLiIoVtkLAOZ5UJ-JFjqOv-1dNMEw

Published financial data: NUGEN MEDICAL DEVICES INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	138K	152K	331K	1.01M	258K
Total Revenues	138K	152K	331K	1.01M	258K
Cost of Goods Sold, Total	45.42K	53.19K	167K	488K	126K
Gross Profit	92.22K	99.17K	165K	522K	132K
Selling General & Admin Expenses, Total	5.26M	4.24M	7.52M	5.03M	3.66M
Stock-Based Compensation (IS)	-	-	-	-	-
Depreciation & Amortization - (IS)	627K	652K	691K	646K	691K
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses, Total	5.88M	4.89M	8.21M	5.68M	4.35M
Operating Income	-5.79M	-4.79M	-8.05M	-5.16M	-4.22M
Interest Expense, Total	-983K	-1.01M	-1.24M	-1.67M	-3.06M
Interest And Investment Income	20K	-	-	-	-
Net Interest Expenses	-963K	-1.01M	-1.24M	-1.67M	-3.06M
Currency Exchange Gains (Loss)	300K	-101K	-114K	-109K	-97.21K
Other Non Operating Income (Expenses)	-1.36M	63.54K	20.46K	43.08K	187K
EBT, Excl. Unusual Items	-7.82M	-5.84M	-9.38M	-6.89M	-7.19M
Asset Writedown	-164K	-	-	-	-4.81M
Other Unusual Items	877K	268K	49.01K	1.67M	4.23M
EBT, Incl. Unusual Items	-7.1M	-5.57M	-9.33M	-5.22M	-7.77M
Income Tax Expense	2.96K	3.18K	33.8K	6.74K	51.97K
Earnings From Continuing Operations	-7.11M	-5.58M	-9.36M	-5.23M	-7.83M
Net Income to Company	-7.11M	-5.58M	-9.36M	-5.23M	-7.83M
Net Income - (IS)	-7.11M	-5.58M	-9.36M	-5.23M	-7.83M
Net Income to Common Incl Extra Items	-7.11M	-5.58M	-9.36M	-5.23M	-7.83M
Net Income to Common Excl. Extra Items	-7.11M	-5.58M	-9.36M	-5.23M	-7.83M
Per Share Items
Net EPS - Basic	-0.1	-0.06	-0.06	-0.02	-0.03
Basic EPS - Continuing Operations	-0.1	-0.06	-0.06	-0.02	-0.03
Basic Weighted Average Shares Outstanding	68.67M	90.1M	168M	214M	227M
Net EPS - Diluted	-0.1	-0.06	-0.06	-0.02	-0.03
Diluted EPS - Continuing Operations	-0.1	-0.06	-0.06	-0.02	-0.03
Diluted Weighted Average Shares Outstanding	68.67M	90.1M	168M	214M	227M
Normalized Basic EPS	-0.07	-0.04	-0.03	-0.02	-0.02
Normalized Diluted EPS	-0.07	-0.04	-0.03	-0.02	-0.02
Supplemental Items
EBITDA	-5.17M	-4.22M	-7.44M	-4.54M	-3.53M
EBITA	-5.18M	-4.23M	-7.44M	-4.54M	-3.57M
EBIT	-5.79M	-4.79M	-8.05M	-5.16M	-4.22M
EBITDAR	-4.96M	-4.13M	-7.32M	-4.35M	-3.31M
Effective Tax Rate - (Ratio)	-0.04	-0.06	-0.36	-0.13	-0.67
Total Current Taxes	2.96K	3.18K	33.8K	6.74K	51.97K
Normalized Net Income	-4.89M	-3.65M	-5.86M	-4.31M	-4.49M
Interest on Long-Term Debt	983K	1.01M	1.24M	1.67M	3.06M
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	-	-	-	-
General and Administrative Expenses	-	-	3.93M	2.95M	1.76M
Research And Development Expense From Footnotes	-	-	-	532K	566K
Net Rental Expense, Total	208K	92.01K	112K	183K	221K
Imputed Operating Lease Interest Expense	258K	114K	145K	190K	308K
Imputed Operating Lease Depreciation	-49.48K	-22.4K	-32.8K	-7.18K	-86.52K
Stock-Based Comp., SG&A Exp. (Total)	1.31M	432K	1.36M	94.69K	-
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	1.31M	432K	1.36M	94.69K	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.75M	131K	464K	6.95M	3.14M
Total Cash And Short Term Investments	1.75M	131K	464K	6.95M	3.14M
Accounts Receivable, Total	11.22K	5.74K	20.75K	99.96K	50.71K
Other Receivables	300K	238K	334K	230K	64.75K
Notes Receivable	-	-	-	-	-
Total Receivables	311K	243K	355K	330K	115K
Inventory	12.9K	76.77K	209K	321K	498K
Prepaid Expenses	71.97K	115K	250K	155K	189K
Restricted Cash	-	-	50.38K	51.94K	53.38K
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	2.15M	567K	1.33M	7.8M	3.99M
Gross Property Plant And Equipment	40.85K	176K	49.98K	34.71K	363K
Accumulated Depreciation	-22.58K	-13.48K	-19.11K	-25.31K	-63.61K
Net Property Plant And Equipment	18.27K	163K	30.87K	9.4K	299K
Goodwill	1.67M	1.67M	1.69M	1.73M	-
Other Intangibles, Total	5.02M	4.45M	3.89M	3.36M	0
Total Assets	8.84M	6.85M	6.95M	12.89M	4.29M
Liabilities
Accounts Payable, Total	878K	1.44M	971K	666K	525K
Accrued Expenses, Total	347K	43.63K	65.73K	-	-
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	83.46K	2.14M	575K	2.98M
Current Portion of Leases	-	117K	27.11K	-	-
Current Income Taxes Payable	-	-	25.47K	6.74K	51.97K
Unearned Revenue Current, Total	-	36.79K	52.31K	82.46K	65.98K
Other Current Liabilities	7K	7K	7K	7K	7K
Total Current Liabilities	1.23M	1.73M	3.29M	1.34M	3.63M
Long-Term Debt	5.61M	7.16M	5.72M	17.23M	14.4M
Long-Term Leases	-	44.07K	-	-	-
Other Non Current Liabilities	346K	175K	-	-	-
Total Liabilities	7.19M	9.11M	9.01M	18.57M	18.03M
Common Stock, Total	14.19M	15.07M	21.36M	23.22M	23.3M
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	-15.81M	-20.61M	-29.3M	-34.37M	-40.83M
Comprehensive Income and Other	3.28M	3.27M	5.88M	5.48M	3.79M
Total Common Equity	1.66M	-2.26M	-2.06M	-5.67M	-13.74M
Total Equity	1.66M	-2.26M	-2.06M	-5.67M	-13.74M
Total Liabilities And Equity	8.84M	6.85M	6.95M	12.89M	4.29M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	86.01M	169M	216M	227M	227M
ECS Total Common Shares Outstanding	86.01M	96.56M	199M	226M	227M
Book Value / Share	0.02	-0.02	-0.01	-0.03	-0.06
Tangible Book Value	-5.02M	-8.38M	-7.65M	-10.75M	-13.74M
Tangible Book Value Per Share	-0.06	-0.09	-0.04	-0.05	-0.06
Total Debt	5.61M	7.41M	7.88M	17.8M	17.38M
Net Debt	3.86M	7.28M	7.42M	10.86M	14.24M
Debt Equivalent Oper. Leases	1.67M	736K	894K	1.46M	1.77M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Finished Goods, Total	-	-	-	-	104K
Inventories - Others	-	-	-	-	395K
Machinery, Total	40.85K	21.31K	24.34K	34.71K	363K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-7.11M	-5.58M	-9.36M	-5.23M	-7.83M
Depreciation & Amortization - CF	12.79K	85.12K	84.43K	32.12K	37.54K
Amortization of Goodwill and Intangible Assets - (CF)	614K	567K	606K	614K	654K
Depreciation & Amortization, Total	627K	652K	691K	646K	691K
Asset Writedown & Restructuring Costs	164K	-	-	-	4.81M
Stock-Based Compensation (CF)	1.31M	432K	1.36M	94.69K	-
Other Operating Activities, Total	1.14M	1.76M	1.32M	111K	-1.02M
Change In Accounts Receivable	-8.1K	5.48K	-15.01K	-79.21K	44.43K
Change In Inventories	-3.19K	-63.87K	-133K	-111K	-225K
Change In Accounts Payable	-25.72K	606K	-362K	-380K	-133K
Change in Unearned Revenues	-	36.79K	15.52K	30.15K	-16.49K
Change In Income Taxes	-	-	-	-	-
Change in Other Net Operating Assets	-191K	19.16K	-232K	201K	107K
Cash from Operations	-4.1M	-2.13M	-6.71M	-4.71M	-3.57M
Capital Expenditure	-3.57K	-1.01K	-3.02K	-10.38K	-302K
Cash Acquisitions	5.29K	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Other Investing Activities, Total	-	-	-50.38K	-1.57K	-1.44K
Cash from Investing	1.72K	-1.01K	-53.4K	-11.94K	-304K
Long-Term Debt Issued, Total	125K	-	-	10M	-
Total Debt Issued	125K	-	-	10M	-
Long-Term Debt Repaid, Total	-50K	-83.89K	-871K	-27.79K	-
Total Debt Repaid	-50K	-83.89K	-871K	-27.79K	-
Issuance of Common Stock	5.51M	673K	7.97M	1.24M	60.5K
Other Financing Activities, Total	-	-75K	-	-	-
Cash from Financing	5.58M	514K	7.1M	11.21M	60.5K
Foreign Exchange Rate Adjustments	-16.99K	-	-	-	-
Net Change in Cash	1.47M	-1.62M	333K	6.48M	-3.81M
Supplemental Items
Cash Interest Paid	7.5K	-	-	-	-
Cash Income Tax Paid (Refund)	2.96K	3.18K	8.32K	-	-
Levered Free Cash Flow	-2.49M	-2.29M	-4.59M	-3.89M	-4.27M
Unlevered Free Cash Flow	-1.88M	-1.66M	-3.82M	-2.84M	-2.36M
Change In Net Working Capital	189K	-258K	838K	351K	111K
Net Debt Issued / Repaid	75K	-83.89K	-871K	9.97M	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-30.93	-38.18	-72.93	-32.49	-30.7
Return on Total Capital	-52.94	-48.29	-91.72	-35.9	-33.44
Return On Equity %	-1.47K	1.85K	433.16	135.17	80.65
Return on Common Equity	-1.47K	1.85K	433.16	135.17	80.65
Margin Analysis
Gross Profit Margin %	67	65.09	49.74	51.68	51.31
SG&A Margin	3.82K	2.78K	2.27K	498.44	1.42K
EBITDA Margin %	-3.75K	-2.77K	-2.24K	-449.33	-1.37K
EBITA Margin %	-3.76K	-2.77K	-2.25K	-449.94	-1.38K
EBIT Margin %	-4.21K	-3.15K	-2.43K	-510.7	-1.64K
Income From Continuing Operations Margin %	-5.16K	-3.66K	-2.83K	-517.47	-3.03K
Net Income Margin %	-5.16K	-3.66K	-2.83K	-517.47	-3.03K
Net Avail. For Common Margin %	-5.16K	-3.66K	-2.83K	-517.47	-3.03K
Normalized Net Income Margin	-3.55K	-2.4K	-1.77K	-426.52	-1.74K
Levered Free Cash Flow Margin	-1.81K	-1.5K	-1.38K	-384.94	-1.66K
Unlevered Free Cash Flow Margin	-1.36K	-1.09K	-1.15K	-281.67	-915.12
Asset Turnover
Asset Turnover	0.01	0.02	0.05	0.1	0.03
Fixed Assets Turnover	6.02	1.68	3.42	50.15	1.67
Receivables Turnover (Average Receivables)	19.19	17.96	25.02	16.73	3.42
Inventory Turnover (Average Inventory)	4.02	1.19	1.16	1.84	0.31
Short Term Liquidity
Current Ratio	1.74	0.33	0.4	5.84	1.1
Quick Ratio	1.67	0.22	0.25	5.44	0.9
Operating Cash Flow to Current Liabilities	-3.32	-1.23	-2.04	-3.53	-0.98
Days Sales Outstanding (Average Receivables)	19.02	20.32	14.59	21.87	106.6
Days Outstanding Inventory (Average Inventory)	90.85	307.67	313.43	198.78	1.19K
Average Days Payable Outstanding	6.38K	3.62K	1.47K	499.75	716.68
Cash Conversion Cycle (Average Days)	-6.27K	-3.29K	-1.14K	-279.1	579.92
Long Term Solvency
Total Debt/Equity	338.29	-327.38	-382.69	-313.91	-126.52
Total Debt / Total Capital	77.18	143.98	135.37	146.75	477.09
LT Debt/Equity	338.29	-318.53	-277.41	-303.78	-104.82
Long-Term Debt / Total Capital	77.18	140.09	98.13	142.01	395.27
Total Liabilities / Total Assets	81.26	133.03	129.66	143.99	420.03
EBIT / Interest Expense	-5.89	-4.74	-6.51	-3.09	-1.38
EBITDA / Interest Expense	-5.25	-4.09	-5.95	-2.7	-1.15
(EBITDA - Capex) / Interest Expense	-5.26	-4.1	-5.95	-2.71	-1.25
Total Debt / EBITDA	-1.09	-1.79	-1.07	-3.95	-4.92
Net Debt / EBITDA	-0.75	-1.76	-1.01	-2.41	-4.03
Total Debt / (EBITDA - Capex)	-1.09	-1.79	-1.07	-3.94	-4.54
Net Debt / (EBITDA - Capex)	-0.75	-1.76	-1.01	-2.4	-3.72
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	191.04	10.69	117.52	204.73	-74.46
Gross Profit, 1 Yr. Growth %	168.21	7.53	66.22	216.63	-74.64
EBITDA, 1 Yr. Growth %	132.31	-18.36	76.33	-38.98	-21.77
EBITA, 1 Yr. Growth %	132.18	-18.37	76.06	-38.94	-21.5
EBIT, 1 Yr. Growth %	123.65	-17.23	67.88	-35.92	-18.17
Earnings From Cont. Operations, 1 Yr. Growth %	93.63	-21.52	67.84	-44.18	49.76
Net Income, 1 Yr. Growth %	93.63	-21.52	67.84	-44.18	49.76
Normalized Net Income, 1 Yr. Growth %	131.51	-25.2	60.49	-26.51	4.32
Diluted EPS Before Extra, 1 Yr. Growth %	52.53	-40.18	-9.8	-56.35	41.53
Accounts Receivable, 1 Yr. Growth %	259.78	-48.86	261.53	381.7	-49.27
Inventory, 1 Yr. Growth %	32.8	495.19	172.6	53.25	55.34
Net Property, Plant and Equip., 1 Yr. Growth %	-33.54	791.09	-81.04	-69.54	3.08K
Total Assets, 1 Yr. Growth %	-39.26	-22.56	1.41	85.65	-66.72
Tangible Book Value, 1 Yr. Growth %	-42.63	66.88	-8.79	40.66	27.72
Common Equity, 1 Yr. Growth %	-339.49	-236.47	-8.94	175.29	142.17
Cash From Operations, 1 Yr. Growth %	193.84	-47.96	215.07	-29.79	-24.35
Capital Expenditures, 1 Yr. Growth %	-35.37	-71.82	200.1	243.32	2.81K
Levered Free Cash Flow, 1 Yr. Growth %	211.75	-13.21	100.6	-15.29	9.91
Unlevered Free Cash Flow, 1 Yr. Growth %	248.75	-11.85	130.54	-25.47	-17.01
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	79.48	55.16	157.46	-11.78
Gross Profit, 2 Yr. CAGR %	-	69.82	33.69	129.42	-10.39
EBITDA, 2 Yr. CAGR %	63.81	37.72	19.99	3.73	-31.1
EBITA, 2 Yr. CAGR %	63.97	37.67	19.88	3.68	-30.77
EBIT, 2 Yr. CAGR %	73.42	36.05	17.88	3.72	-27.58
Earnings From Cont. Operations, 2 Yr. CAGR %	89.33	23.28	14.77	-3.21	-8.57
Net Income, 2 Yr. CAGR %	89.33	23.28	14.77	-3.21	-8.57
Normalized Net Income, 2 Yr. CAGR %	95.32	31.54	9.57	8.6	-12.44
Diluted EPS Before Extra, 2 Yr. CAGR %	11.12	-4.48	-26.55	-37.26	-21.41
Accounts Receivable, 2 Yr. CAGR %	-	35.64	35.97	317.31	56.32
Inventory, 2 Yr. CAGR %	-	181.14	302.8	104.39	54.29
Net Property, Plant and Equip., 2 Yr. CAGR %	-16.56	143.36	29.99	-75.97	211.31
Total Assets, 2 Yr. CAGR %	305.2	-31.42	-11.38	37.21	-21.39
Tangible Book Value, 2 Yr. CAGR %	137.05	-2.16	23.37	13.27	34.03
Common Equity, 2 Yr. CAGR %	52.92	80.78	11.48	58.33	158.2
Cash From Operations, 2 Yr. CAGR %	50.53	23.65	28.04	48.73	-27.12
Capital Expenditures, 2 Yr. CAGR %	-	-57.33	-8.05	220.98	900.19
Levered Free Cash Flow, 2 Yr. CAGR %	44.94	69.16	31.95	30.36	-3.51
Unlevered Free Cash Flow, 2 Yr. CAGR %	29.46	75.33	42.55	31.08	-21.35
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	91.36	94.31	19.19
Gross Profit, 3 Yr. CAGR %	-	-	68.62	78.21	10.1
EBITDA, 3 Yr. CAGR %	45.97	29.88	49.55	-4.23	-5.76
EBITA, 3 Yr. CAGR %	46.05	29.95	49.43	-4.26	-5.5
EBIT, 3 Yr. CAGR %	51.61	35.52	45.93	-3.79	-4.16
Earnings From Cont. Operations, 3 Yr. CAGR %	58.3	41.17	36.63	-9.74	11.95
Net Income, 3 Yr. CAGR %	58.3	41.17	36.63	-9.74	11.95
Normalized Net Income, 3 Yr. CAGR %	63.4	41.8	40.56	-4.09	7.16
Diluted EPS Before Extra, 3 Yr. CAGR %	4.31	-9.6	-6.29	-38.25	-17.71
Accounts Receivable, 3 Yr. CAGR %	-	-	88.06	107.28	106.73
Inventory, 3 Yr. CAGR %	-	-	178.27	191.87	86.53
Net Property, Plant and Equip., 3 Yr. CAGR %	64.85	83.75	3.94	-19.86	22.49
Total Assets, 3 Yr. CAGR %	58.73	133.4	-21.87	13.39	-14.43
Tangible Book Value, 3 Yr. CAGR %	64.39	110.88	-4.42	28.89	17.89
Common Equity, 3 Yr. CAGR %	9.62	47.23	43.84	50.68	82.42
Cash From Operations, 3 Yr. CAGR %	44.78	5.65	68.89	4.8	18.72
Capital Expenditures, 3 Yr. CAGR %	22.72	-	-18.24	42.65	569.59
Levered Free Cash Flow, 3 Yr. CAGR %	42.48	24.46	79.05	13.83	23.15
Unlevered Free Cash Flow, 3 Yr. CAGR %	34.25	13.89	92.08	14.84	12.55
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	40.39
Gross Profit, 5 Yr. CAGR %	-	-	-	-	30.94
EBITDA, 5 Yr. CAGR %	-	47.3	34.96	18.71	9.68
EBITA, 5 Yr. CAGR %	-	47.29	34.96	18.73	9.85
EBIT, 5 Yr. CAGR %	-	51.04	37.09	21.77	10.26
Earnings From Cont. Operations, 5 Yr. CAGR %	-	50.81	39.19	21.39	16.35
Net Income, 5 Yr. CAGR %	-	50.81	39.19	21.39	16.35
Normalized Net Income, 5 Yr. CAGR %	-	52.22	39.24	27.45	16.32
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-9.34	-21.89	-12.66
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	74.66
Inventory, 5 Yr. CAGR %	-	-	-	-	119.79
Net Property, Plant and Equip., 5 Yr. CAGR %	-	116.38	49.91	-18.56	61.19
Total Assets, 5 Yr. CAGR %	-	51.32	25.72	88.72	-21.68
Tangible Book Value, 5 Yr. CAGR %	-	191.81	46.56	64.46	9.42
Common Equity, 5 Yr. CAGR %	-	117.18	10.36	51.57	81.77
Cash From Operations, 5 Yr. CAGR %	-	35.67	37.84	21.13	20.67
Capital Expenditures, 5 Yr. CAGR %	-	-39.13	9.34	-	122.61
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	39.73	26.79	39.82
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	37.51	20.48	34.39